André Chung for STAT

STAT+ | Concerns grow on safety issues tied to Neurocrine Biosciences rare disease drug

A former FDA regulator wants the Prader-Willi therapy, Vykat XR, withdrawn, but others are urging caution on drawing conclusions.

By Adam Feuerstein

Americans trust science more than peers around the world, survey shows

While the U.S. may, in general, appreciate and trust science more than other countries do, it is also far more divided than peer nations.

By Nicholas Florko

STAT+ | Opinion: The epidemic of learned helplessness in physicians

Medical training teaches doctors deference. Increasingly, that deference seems to follow them through their careers.

By Frances Mei Hardin

Sarah Gonzalez for STAT

Helen Branswell, whose reporting on infectious diseases and public health drew acclaim, dies at 69

Branswell, who died on Oct. 13, became a vital source of information for the public during the Covid-19 pandemic and other outbreaks.

By Andrew Joseph

STAT+ | FTC demands Martin Shkreli divest his pharma stocks

Shkreli, convicted of defrauding investors, was banned from working in the drug industry. FTC says it should include his pharma stock trading

By Jason Mast

STAT+ | Many patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds

11% of advisory committee meetings included a rep affiliated with an organization receiving funds from a company whose drug was under review.

By Ed Silverman

California Department of Corrections and Rehabilitation via Getty Images

Opinion: Lethal injection will never be the same after Christa Pike’s botched execution

Pre-Christa Pike, lethal injection was “passing” as a “death with dignity” medical assistance in dying procedure. No more.

By M. Sara Rosenthal